Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
Status:
Completed
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of infliximab (an
anti-TNF chimeric monoclonal antibody [cA2]) in patients with active Rheumatoid Arthritis,
despite methotrexate treatment.